Oruka Therapeutics Inc.
ORKA | NASDAQ
$95.68
-$1.19 (-1.23%)
Nov 2, 2026, 12:52 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 114K | 71K | 28K | n/a | n/a | n/a | 19K | 42K | 72K | 101K | 111K | 117K | 115K | 115K | 114K | 113K | 112K | 102K | 91K | 79K | 78K | 85K |
Gross Profit | -114K | -71K | -28K | n/a | n/a | n/a | -19K | -42K | -72K | -101K | -111K | -117K | -115K | -115K | -114K | -113K | -112K | -102K | -91K | -79K | -78K | -85K |
Operating Income | -155.08M | -133.4M | -122.05M | -125.95M | -121.29M | -114.36M | -91.75M | -55.01M | -27.5M | -7.98M | -7.3M | -7.29M | -7.11M | -7.57M | -9.05M | -13.15M | -16.1M | -18.51M | -19.34M | -18.78M | -16.06M | -12.53M |
Interest Income | 22.18M | 17.14M | 16.63M | 16.31M | 13.81M | 10.4M | 6.78M | 2.75M | 1.93M | 1.98M | 1.96M | 2.13M | 1.62M | 1.13M | 675K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -132.89M | -116.25M | -105.43M | -109.24M | -107.59M | -105.26M | -86.27M | -53.96M | -26.77M | -6M | -5.34M | -5.42M | -6.33M | -8M | -9.93M | -14.43M | -16.81M | -18.49M | -19.32M | -18.77M | -16.05M | -12.53M |
Net Income | -132.89M | -116.25M | -105.43M | -109.24M | -107.59M | -105.26M | -86.27M | -53.96M | -26.77M | -6M | -5.34M | -5.42M | -6.33M | -8M | -9.93M | -14.43M | -16.81M | -18.49M | -19.32M | -18.77M | -16.05M | -12.52M |
Selling & General & Admin | 25.93M | 23.47M | 21.38M | 20.62M | 19.26M | 17.74M | 14.25M | 9.77M | 7.6M | 6.47M | 6.17M | 5.94M | 5.56M | 5.27M | 4.96M | 5.39M | 5.44M | 5.27M | 5.41M | 5.61M | 5.27M | 4.94M |
Research & Development | 129.03M | 109.86M | 100.64M | 105.33M | 102.03M | 96.62M | 76.86M | 44.58M | 19.21M | 788K | 1.01M | 1.23M | 1.44M | 2.19M | 3.97M | 7.65M | 10.55M | 13.14M | 13.83M | 13.1M | 10.71M | 7.5M |
Other Expenses | n/a | n/a | n/a | 0 | 0 | 0 | 628K | 628K | 628K | 628K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 154.96M | 133.33M | 122.02M | 125.95M | 121.29M | 114.36M | 91.73M | 54.97M | 27.43M | 7.88M | 7.19M | 7.17M | 7M | 7.46M | 8.94M | 13.04M | 15.99M | 18.41M | 19.24M | 18.7M | 15.98M | 12.44M |
Interest Expense | n/a | n/a | n/a | n/a | 504K | 504K | 504K | 504K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | 5K |
Selling & Marketing Expenses | 200K | 200K | 200K | 527.27K | 427.27K | 427.27K | 427.27K | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 155.08M | 133.4M | 122.05M | 125.95M | 121.29M | 114.36M | 91.75M | 55.01M | 27.5M | 7.98M | 7.3M | 7.29M | 7.11M | 7.57M | 9.05M | 13.15M | 16.1M | 18.51M | 19.34M | 18.78M | 16.06M | 12.53M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9K |
Shares Outstanding (Basic) | 62.87M | 55.17M | 54.42M | 44.07M | 42.23M | 41.68M | 16.79M | 15.01M | 14.51M | 14.5M | 14.42M | 14.41M | 14.41M | 14.41M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.03M |
Shares Outstanding (Diluted) | 62.87M | 55.17M | 54.42M | 44.07M | 42.23M | 41.68M | 16.79M | 15.01M | 14.51M | 14.5M | 14.42M | 14.41M | 14.41M | 14.41M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.03M |
EPS (Basic) | -2.47 | -2.39 | -2.31 | -3.31 | -4.53 | -5.25 | -4.99 | -4.35 | -3.63 | -3.56 | -4.44 | -4.52 | -5.27 | -6.66 | -8.26 | -12.01 | -13.99 | -15.40 | -16.66 | -18.37 | -18.40 | -23.08 |
EPS (Diluted) | -2.47 | -2.39 | -2.31 | -3.31 | -4.53 | -5.25 | -4.99 | -4.35 | -3.63 | -3.56 | -4.44 | -4.52 | -5.27 | -6.66 | -8.26 | -12.01 | -13.99 | -15.40 | -16.66 | -18.37 | -18.40 | -23.08 |
EBITDA | -141.65M | -116.14M | -105.35M | -113.23M | -111.09M | -108.77M | -89.78M | -53.41M | -26.68M | -5.9M | -5.23M | -5.31M | -6.22M | -7.89M | -9.81M | -14.32M | -16.7M | -18.39M | -19.23M | -18.69M | -15.97M | -12.44M |
EBIT | -141.79M | -116.25M | -105.43M | -113.31M | -111.15M | -108.82M | -89.83M | -53.46M | -26.77M | -6M | -5.34M | -5.42M | -6.33M | -8M | -9.93M | -14.43M | -16.81M | -18.49M | -19.32M | -18.77M | -16.05M | -12.52M |
Depreciation & Amortization | 134K | 110K | 83K | 73.46K | 53.46K | 46.46K | 49.46K | 54K | 84K | 101K | 111K | 117K | 115K | 115K | 114K | 113K | 112K | 102K | 91K | 79K | 78K | 85K |
Add to Watchlist
Select watchlists to add or remove ORKA